Study guide

New Diagnosis Navigation and Treatment Planning Case Lab

OCN Oncology Certified Nurse Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: OCN Exam Orientation and Official Source Control

Official Sources and Credential Purpose Eligibility, Application, and Fees Exam Format, Scoring, Blueprint, and Generic Drugs PSI Scheduling, ATT, Test Day, and Results Blueprint-Based Study Plan and Readiness

2 Chapter 2: Care Continuum, Prevention, Survivorship, and End-of-Life Care

Health Promotion, Risk Reduction, and Epidemiology Screening, Early Detection, and High-Risk Referrals Navigation, Coordination, and Care Continuity Palliative Care, Advance Care Planning, and Goals Survivorship, Rehabilitation, Recurrence, and Late Effects Sexuality, Family Support, Discrimination, and Social Needs End-of-Life Care, Hospice, Bereavement, and Comfort Measures

3 Chapter 3: Oncology Science and Site-Specific Cancer Assessment

Carcinogenesis, Immunology, and Cancer Biology Genomic, Genetic Testing, and Biomarker Literacy Clinical Trials, Research Protocols, and Informed Participation Diagnostic Workup, Biopsy, Imaging, and Pathology Basics Staging, Grading, Prognosis, and Performance Status Common Cancer Patterns and Metastatic Sites Oncology Assessment, Data Clustering, and Escalation

4 Chapter 4: Professional Oncology Nursing Practice, Safety, and Standards

Scope, Standards, Nursing Process, and Documentation Collaboration, Communication, and Interprofessional Practice Safe Handling, PPE, Occupational Health, and Exposure Response Culturally Congruent Care, Advocacy, and Ethics Self-Care, Compassion Fatigue, Burnout, and Professional Development

5 Chapter 5: Treatment Modalities I - Surgery, Radiation, Transplant, Localized and Oral Therapy

Surgery and Procedural Oncology Nursing Care Radiation Therapy Principles, Toxicities, and Teaching Blood and Marrow Transplant Foundations Localized Therapy: Intrathecal, Intravesical, and Regional Care Oral Oncology Therapy Adherence, Safety, and Education Treatment Sequencing, Response Monitoring, and Care Coordination Modality-Specific Patient Teaching and Documentation

6 Chapter 6: Treatment Modalities II - Systemic Therapy, Immunotherapy, and Targeted Agents

Chemotherapy Foundations and Infusion Safety Biotherapy, Immunotherapy, and Immune-Related Adverse Events Targeted Therapy, Immune Cell, and Bispecific Antibody Basics Hormonal Therapy and Endocrine Cancer Treatment Considerations Vascular Access, Infusion Monitoring, and Extravasation Prevention Systemic Therapy Patient Education and Home Safety Therapy Response, Adherence, and Toxicity Escalation

7 Chapter 7: Symptom Management and Supportive Care

Symptom Assessment, Toxicity Grading, and Prioritization Hematologic, Immunologic, and Infection Supportive Care GI, GU, Nutrition, and Hydration Supportive Care Integumentary, Ostomy, Lymphedema, and Wound Care Respiratory, Cardiovascular, Neurologic, and Musculoskeletal Symptoms Pain Management, Pharmacologic, and Integrative Care Vascular Access Device Care and Supportive Care Coordination

8 Chapter 8: Oncologic Emergencies and Rapid Escalation

Sepsis, SIRS, Neutropenic Infection, and Shock Tumor Lysis, Hypercalcemia, SIADH, and Metabolic Emergencies Hypersensitivity, Anaphylaxis, and Infusion Reactions Spinal Cord Compression, SVC Syndrome, Increased ICP, and Obstructions DIC, VTE, Bleeding, and Thrombotic Emergencies Pneumonitis, Extravasation, and Local Therapy Emergencies Immune-Related Emergencies, CRS, ICANS, and Urgent Triage

9 Chapter 9: Psychosocial Dimensions of Oncology Care

Distress Screening, Emotional Response, and Crisis Care Cultural, Spiritual, Religious, and Language-Responsive Care Family, Caregiver Support, and Shared Decision-Making Sexuality, Fertility, Gender, and Body Image Concerns Learning Barriers, Health Literacy, and Patient Education Financial Toxicity, Support Systems, and Resource Referrals

10 Chapter 10: Mixed OCN Case Labs

New Diagnosis Navigation and Treatment Planning Case Lab Chemotherapy Infusion Reaction and Extravasation Case Lab Immunotherapy Toxicities and CRS ICANS Case Lab Radiation Surgery and Localized Therapy Case Lab Symptom Management Neutropenia Pain and Nutrition Case Lab Oncologic Emergency TLS SVC Cord Compression Case Lab Survivorship Palliative Psychosocial and Discharge Case Lab

11 Chapter 11: Final Review, High-Yield Tables, and OCN Exam-Day Readiness

Blueprint Quick Reference and Domain Triage High-Yield Oncology Safety and Emergency Tables Generic Drug Stems, Labs, and Supportive Care Patterns Final Week Practice Plan, Error Log, and Stamina Final 48 Hours, PSI Test Day, and Retake Planning

New Diagnosis Navigation and Treatment Planning Case Lab

Key Takeaways Explain This Topic AI

Before reinforcing any plan, verify pathology, stage, biomarkers, ECOG performance status, comorbidities, baseline labs, goals, and red-flag symptoms.

Navigation is an active role: arrange interpreters, obtain outside records, close appointment gaps, and screen distress with the NCCN Distress Thermometer (0-10).

RN scope = assess, educate in plain language, triage, refer, and reassess; it never includes staging, prescribing, or obtaining the surgeon's informed consent.

Escalate obstruction symptoms, uncontrolled pain, bleeding, fever, severe anemia symptoms, NCCN distress >=4, suicidal statements, or consent confusion.

Route every supplement and herbal product to pharmacy and oncology before use because of bleeding, hepatic, and efficacy interactions.

Last updated: June 2026

Case Lab: New Diagnosis Navigation and Treatment Planning

The Oncology Certified Nurse (OCN) examination, administered by the Oncology Nursing Certification Corporation (ONCC) through PSI, delivers 165 multiple-choice questions (145 scored, 20 unscored pretest items) in a 3-hour session; the passing scaled score is 55 . The Care Continuum domain is the single largest blueprint slice, and new-diagnosis navigation items live here. Expect first-action and priority-setting questions that reward organizing data, not reciting facts.

Case Snapshot

A 54-year-old has a new diagnosis of stage III colon cancer after colonoscopy and biopsy. The surgeon discussed resection followed by likely adjuvant chemotherapy; the medical oncology visit is in one week. The patient arrives with fatigue, intermittent abdominal cramping, iron-deficiency anemia (hemoglobin 9.4 g/dL), a spouse with limited English, and a folder of results. The patient says, "I do not know whether I am having surgery, chemotherapy, or both," and asks whether an herbal immune booster can start tonight.

OCN Framing and First Priorities

This case spans care continuum, treatment modalities, symptom management, psychosocial dimensions, and safety. The nurse does not stage the cancer, prescribe therapy, interpret molecular results as a provider, or obtain the surgeon's consent. The nurse verifies what was communicated, assesses understanding, identifies immediate risk, reinforces the plan in plain language, and closes gaps that could delay treatment.

Priority RN Action Escalate When

Diagnostic clarity Confirm pathology, imaging, referrals, and appointment dates Records missing, plan unclear, or patient denies a cancer diagnosis was given

Baseline safety Review symptoms, vitals, CBC/CMP, meds, allergies, nutrition, transport Obstruction symptoms, fever, bleeding, Hgb <7 with symptoms, unsafe home

Treatment readiness Explain the likely sequence as provisional and provider-directed Consent confusion or refusal based on misinformation

Barriers Screen distress (NCCN Distress Thermometer 0-10), finances, language, caregiving Distress >=4, self-harm statements, no interpreter access

The first priority is never a long chemotherapy lecture. Determine clinical stability. Worsening distention, persistent vomiting, inability to pass stool or gas, severe pain, fever, syncope, or active bleeding can signal bowel obstruction, perforation, infection, or hemodynamic compromise and require same-day evaluation. If stable, organize the case around what must precede treatment: pathology confirmation, staging scans, surgical clearance, baseline labs, medication reconciliation, ECOG performance status, comorbidity review, and access planning.

Education Within RN Scope

Teaching is concrete and paced. The nurse explains that surgery, systemic therapy, radiation, targeted therapy, immunotherapy, or surveillance may be used alone or in sequence by tumor type and stage. Avoid guaranteeing cure, minimizing toxicity, or stating chemotherapy is certain before the oncologist finalizes the regimen. Teach how to reach the team, which symptoms require urgent contact, to bring all medication bottles and supplements to visits, and why baseline dental or fertility referrals matter for some plans.

Reportable red flags to teach before treatment:

  • Fever >=38.0 C, shaking chills, or any sign of infection
  • New or worsening abdominal pain, distention, or no stool/gas
  • Bleeding, black stools, or dizziness on standing
  • Inability to keep fluids down for more than 24 hours

For the herbal immune booster , safety leads. Ask the product, dose, source, and reason, then advise holding it until oncology and pharmacy review. Supplements alter bleeding risk, hepatic CYP metabolism, renal clearance, sedation, and treatment efficacy (for example, St. John's wort induces CYP3A4 and can lower chemotherapy levels). Document the product and route it for medication review rather than approving or forbidding it outright.

Navigation, Documentation, and Reassessment

Navigation is active. Arrange professional interpreter services; a family member is not the interpreter of record for clinical decisions or consent. Verify upcoming appointments, obtain missing outside records, and screen transportation and financial barriers. Initiate a genetic counseling referral per policy when age, family history, or tumor testing suggests inherited risk, but do not promise a hereditary diagnosis. Document baseline symptoms, NCCN distress score, learning needs, preferred language and interpreter use, medication and supplement list, education provided, escalations, referrals, and a timed next contact.

Close the loop: call after the oncology consult to confirm understanding, screen for urgent symptoms, and verify the next appointment. Strong OCN performance links teaching to follow-up: teach, confirm, document, reassess.

Common Exam Traps

The colon-cancer scenario hides several distractors that the OCN exam loves. First, jumping to chemotherapy education before ruling out obstruction is a classic wrong answer: education never outranks an unstable airway, circulation, or acute abdomen. Second, using the limited-English spouse as the interpreter for clinical decisions or consent violates language-access standards and is unsafe even when convenient; the correct answer always names a professional interpreter. Third, either approving or flatly banning the herbal product is wrong; the scope-appropriate action is to assess and route for pharmacy review.

A few anchoring facts worth memorizing for this domain:

ECOG performance status runs 0 (fully active) to 4 (completely disabled); it drives treatment-tolerance decisions and appears in case stems as a tolerance clue.

Iron-deficiency anemia in a new colon-cancer patient (Hgb 9.4 g/dL here) reflects chronic GI blood loss; transfusion thresholds are provider-set, but symptomatic anemia (tachycardia, dizziness, dyspnea) is the escalation trigger, not a number alone.

A closed-loop referral means the nurse confirms the appointment was made and kept, not merely that a referral order was entered.

Genetic counseling for colorectal cancer is considered when age is under 50, there is a strong family history, or tumor testing suggests Lynch syndrome (mismatch-repair deficiency); the RN initiates referral but does not diagnose.

When a stem stacks clinical, psychosocial, and safety data, work the hierarchy: rule out instability, secure language access and consent clarity, then teach and refer. The answer that delays escalation, oversteps RN scope, or skips reassessment is almost always the distractor.